HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[REMOTE 3-YEAR RESULTS OF APPLICATION OF <<INDIRECT>> WAYS OF REVASCULARIZATION IN PATIENTS WITH CHRONIC ISCHEMIA OF LOWER EXTREMITIES].

Abstract
There are several ways of <<indirect>> revascularization such as revascularizated osteotrepanation of shinbone and lumbar sympathectomy (LS) for treatment of patients with chronic ischemia of lower extremities. They appeared to be sufficiently effective for the patients with II stage of the disease. Patients with critical ischemia (III stage) had persistent positive results after lumbar sympathectomy during 3-year period only in 33% of cases and using revacularized osteotrepnation - 46%. The difference in efficacy of treatment using LS and standard conservative therapy is statistically low significant, so that isn't allowed.recommending the sympathectomy for treatment of III stage ischemia. The method of revascularizated osteotrepanation of shinbone showed a reliably better result, therefore this way is reasonable to apply in surgery in case of III stage ischemia.
AuthorsIu V Cherviakov, I N Staroverov, A V Borisov, E G Nersesian, O N Vlasenko, S N LavlinskiÄ­
JournalVestnik khirurgii imeni I. I. Grekova (Vestn Khir Im I I Grek) Vol. 174 Issue 2 Pg. 84-8 ( 2015) ISSN: 0042-4625 [Print] Russia (Federation)
PMID26234071 (Publication Type: English Abstract, Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Humans
  • Ischemia (surgery)
  • Lower Extremity (blood supply)
  • Lumbosacral Plexus
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sympathectomy (methods)
  • Time Factors
  • Treatment Outcome
  • Vascular Surgical Procedures (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: